The effect of size, morphology and surface properties of mesoporous silica nanoparticles on pharmacokinetic aspects and potential toxicity concerns
暂无分享,去创建一个
S. Mohammadi-Samani | Parisa Ghasemiyeh | N. Firouzabadi | Bahareh Hassani | Ghazal Goshtasbi | Uranous Niroumand | U. Niroumand
[1] Fei Liu,et al. The application of mesoporous silica nanoparticles as a drug delivery vehicle in oral disease treatment , 2023, Frontiers in Cellular and Infection Microbiology.
[2] V. Mattoli,et al. Enhancing Methotrexate Delivery in the Brain by Mesoporous Silica Nanoparticles Functionalized with Cell-Penetrating Peptide using in Vivo and ex Vivo Monitoring. , 2023, Molecular pharmaceutics.
[3] Dinesh Nyavanandi,et al. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery , 2023, Nanotheranostics.
[4] W. Grizzle,et al. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery , 2022, Pharmaceutics.
[5] Chenying Fu,et al. Signaling pathways and targeted therapy for myocardial infarction , 2022, Signal Transduction and Targeted Therapy.
[6] Shiyuan Peng,et al. Effect of Surface Functionalization and Pore Structure Type on the Release Performance of Mesoporous Silica Nanoparticles , 2022, Microporous and Mesoporous Materials.
[7] Guangji Wang,et al. Integrative Metabolomics, Proteomics and Transcriptomics Analysis Reveals Liver Toxicity of Mesoporous Silica Nanoparticles , 2022, Frontiers in Pharmacology.
[8] Jie Zhou,et al. Apigenin Attenuates Mesoporous Silica Nanoparticles-Induced Nephrotoxicity by Activating FOXO3a , 2021, Biological Trace Element Research.
[9] Y. Sogo,et al. Biosafety of mesoporous silica nanoparticles: a combined experimental and literature study , 2021, Journal of Materials Science: Materials in Medicine.
[10] J. Engblom,et al. Can mesoporous nanoparticles promote bioavailability of topical pharmaceutics? , 2021, International journal of pharmaceutics.
[11] R. Awasthi,et al. Albumin-Coated Mesoporous Silica Nanoparticles of Docetaxel: Preparation, Characterization, and Pharmacokinetic Evaluation. , 2021, Assay and drug development technologies.
[12] L. McNally,et al. Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect , 2021, Pharmaceutics.
[13] T. Takebe,et al. Human liver model systems in a dish , 2021, Development, growth & differentiation.
[14] Yong Jiang. Pyroptosis in liver disease. , 2020, Revista Espanola de Enfermedades Digestivas.
[15] M. Chorilli,et al. Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration , 2020 .
[16] S. Wuttke,et al. Overcoming the paracetamol dose challenge with wrinkled mesoporous carbon spheres. , 2020, Journal of colloid and interface science.
[17] R. Lin,et al. Development and Characterization of a Glimepiride-Loaded Gelatin-Coated Mesoporous Hollow Silica Nanoparticle Formulation and Evaluation of Its Hypoglycemic Effect on Type-2 Diabetes Model Rats. , 2020, Assay and drug development technologies.
[18] H. Lindberg,et al. Short-term oral administration of non-porous and mesoporous silica did not induce local or systemic toxicity in mice , 2020, Nanotoxicology.
[19] L. Walsh,et al. Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective. , 2020, Journal of materials chemistry. B.
[20] M. Vallet‐Regí,et al. Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines , 2020, Pharmaceutics.
[21] Wuli Yang,et al. Biomimetic Mesoporous Silica Nanoparticles for Enhanced Blood Circulation and Cancer Therapy. , 2020, ACS applied bio materials.
[22] Lixiao Zhou,et al. TiO2 Nanoparticles Caused DNA Damage in Lung and Extra-Pulmonary Organs Through ROS-Activated FOXO3a Signaling Pathway After Intratracheal Administration in Rats , 2020, International journal of nanomedicine.
[23] Y. Qi,et al. STAT3, a key regulator in liver fibrosis. , 2020, Annals of hepatology.
[24] W. Xue,et al. Inhibition of myeloid differentiation protein 2 attenuates renal ischemia/reperfusion-induced oxidative stress and inflammation via suppressing TLR4/TRAF6/NF-kB pathway. , 2020, Life sciences.
[25] Kyle J Isaacson,et al. One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[26] L. Menicanti,et al. The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome , 2020, Journal of Thrombosis and Haemostasis.
[27] H. Khan,et al. In-Vitro and In-Vivo Evaluation of Velpatasvir- Loaded Mesoporous Silica Scaffolds. A Prospective Carrier for Drug Bioavailability Enhancement , 2020, Pharmaceutics.
[28] M. B. Abdul Rahman,et al. Functionalized mesoporous silica nanoparticles templated by pyridinium ionic liquid for hydrophilic and hydrophobic drug release application , 2020 .
[29] V. Niculescu. Mesoporous Silica Nanoparticles for Bio-Applications , 2020, Frontiers in Materials.
[30] Chuanyong Guo,et al. Therapeutic potential of PPARγ natural agonists in liver diseases , 2020, Journal of cellular and molecular medicine.
[31] P. Fu,et al. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[32] Hongxia Liu,et al. PNPLA3 I148M mediates the regulatory effect of NF‐kB on inflammation in PA‐treated HepG2 cells , 2019, Journal of cellular and molecular medicine.
[33] D. Lin,et al. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[34] Yahya E Choonara,et al. The Hemocompatibility of Nanoparticles: A Review of Cell–Nanoparticle Interactions and Hemostasis , 2019, Cells.
[35] Yumei Wang,et al. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect , 2019, Molecules.
[36] A. Farghali,et al. Mesoporous Silica Nanoparticles Trigger Liver and Kidney Injury and Fibrosis Via Altering TLR4/NF-κB, JAK2/STAT3 and Nrf2/HO-1 Signaling in Rats , 2019, Biomolecules.
[37] J. Batra,et al. Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy , 2019, Front. Bioeng. Biotechnol..
[38] A. Mahmoud,et al. Ferulic acid protects against methotrexate nephrotoxicity via activation of Nrf2/ARE/HO-1 signaling and PPARγ, and suppression of NF-κB/NLRP3 inflammasome axis. , 2019, Food & function.
[39] Wenzhen Shi,et al. GCN2 suppression attenuates cerebral ischemia in mice by reducing apoptosis and endoplasmic reticulum (ER) stress through the blockage of FoxO3a-regulated ROS production. , 2019, Biochemical and biophysical research communications.
[40] H. Ghandehari,et al. Subchronic toxicity of silica nanoparticles as a function of size and porosity. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[41] Hassan A. Elgebaly,et al. Olea europaea leaf extract up-regulates Nrf2/ARE/HO-1 signaling and attenuates cyclophosphamide-induced oxidative stress, inflammation and apoptosis in rat kidney. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[42] S. Rajput,et al. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene , 2019, Drug development and industrial pharmacy.
[43] M. Vallet‐Regí,et al. Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties. , 2019, Acta biomaterialia.
[44] Junjie Cheng,et al. Charge-Selective Delivery of Proteins Using Mesoporous Silica Nanoparticles Fused with Lipid Bilayers. , 2019, ACS applied materials & interfaces.
[45] Wei Zhang,et al. Effect of Shape on Mesoporous Silica Nanoparticles for Oral Delivery of Indomethacin , 2018, Pharmaceutics.
[46] C. Brinker,et al. Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics , 2018, Nature Communications.
[47] S. Arpicco,et al. Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles , 2018, Pharmaceutics.
[48] A. Allam,et al. Commiphora molmol protects against methotrexate-induced nephrotoxicity by up-regulating Nrf2/ARE/HO-1 signaling. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[49] D. Klionsky,et al. Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles , 2018, Autophagy.
[50] Cheng Xu,et al. Mesoporous silica nanorods for improved oral drug absorption , 2018, Artificial cells, nanomedicine, and biotechnology.
[51] J. Devoisselle,et al. Biosafety of Mesoporous Silica Nanoparticles , 2018, Biomimetics.
[52] Lei Shang,et al. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin , 2018, Artificial cells, nanomedicine, and biotechnology.
[53] Wei Chen,et al. Mesoporous silica nanoparticles induced hepatotoxicity via NLRP3 inflammasome activation and caspase-1-dependent pyroptosis. , 2018, Nanoscale.
[54] M. Vallet‐Regí,et al. Mesoporous silica nanoparticles in nanomedicine applications , 2018, Journal of Materials Science: Materials in Medicine.
[55] S. Rajput,et al. Etoposide encapsulated functionalized mesoporous silica nanoparticles: Synthesis, characterization and effect of functionalization on dissolution kinetics in simulated and biorelevant media , 2018 .
[56] N. Khashab,et al. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications , 2018, Advanced healthcare materials.
[57] S. Laurent,et al. Toxicity of TiO2 nanoparticles on the NRK52E renal cell line , 2017, Molecular & Cellular Toxicology.
[58] Bruno A. Cisterna,et al. Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses. , 2017, Vascular pharmacology.
[59] F. Wilkinson,et al. The Role of Nrf2 in Cardiovascular Function and Disease , 2017, Oxidative medicine and cellular longevity.
[60] N. Fan,et al. Multimodal nanoporous silica nanoparticles functionalized with aminopropyl groups for improving loading and controlled release of doxorubicin hydrochloride. , 2017, Materials science & engineering. C, Materials for biological applications.
[61] Junchao Duan,et al. Silica nanoparticles induce liver fibrosis via TGF-β1/Smad3 pathway in ICR mice , 2017, International journal of nanomedicine.
[62] Tian Xia,et al. Facilitating Translational Nanomedicine via Predictive Safety Assessment. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[63] L. Aleksunes,et al. Xenobiotic transporters and kidney injury. , 2017, Advanced drug delivery reviews.
[64] Y. Hung,et al. Molecular Elucidation of Biological Response to Mesoporous Silica Nanoparticles in Vitro and in Vivo. , 2017, ACS applied materials & interfaces.
[65] Qinfu Zhao,et al. A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics , 2017, Scientific Reports.
[66] H. Naegeli,et al. MyD88-dependent pro-interleukin-1β induction in dendritic cells exposed to food-grade synthetic amorphous silica , 2017, Particle and Fibre Toxicology.
[67] L. Godderis,et al. Toxicology of silica nanoparticles: an update , 2017, Archives of Toxicology.
[68] D. Oupický,et al. Surface PEGylation of Mesoporous Silica Nanorods (MSNR): Effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells , 2017, Scientific Reports.
[69] D. Oupický,et al. Surface PEGylation of Mesoporous Silica Nanorods (MSNR): Effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells , 2017, Scientific Reports.
[70] Y. Hu,et al. Inhibition of Kupffer Cell Autophagy Abrogates Nanoparticle‐Induced Liver Injury , 2017, Advanced healthcare materials.
[71] O. Farokhzad,et al. Nanomedicines for renal disease: current status and future applications , 2016, Nature Reviews Nephrology.
[72] Chengzhong Yu,et al. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement , 2016, Nanotechnology.
[73] Jing Guan,et al. Blood clot initiation by mesoporous silica nanoparticles: dependence on pore size or particle size? , 2016, Journal of materials chemistry. B.
[74] W. Dai,et al. Amphipathic silica nanoparticles induce cytotoxicity through oxidative stress mediated and p53 dependent apoptosis pathway in human liver cell line HL-7702 and rat liver cell line BRL-3A. , 2016, Colloids and surfaces. B, Biointerfaces.
[75] B. Yan,et al. Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a. , 2016, Experimental and therapeutic medicine.
[76] R. C.-Gaudreault,et al. Size-Controlled Functionalized Mesoporous Silica Nanoparticles for Tunable Drug Release and Enhanced Anti-Tumoral Activity , 2016 .
[77] Nan Zheng,et al. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity. , 2016, Colloids and surfaces. B, Biointerfaces.
[78] Lu Xiao,et al. Zinc oxide nanoparticles induce renal toxicity through reactive oxygen species. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[79] Abderrahim Nemmar,et al. Oxidative stress, inflammation, and DNA damage in multiple organs of mice acutely exposed to amorphous silica nanoparticles , 2016, International journal of nanomedicine.
[80] Mohd Ali Hashim,et al. Superoxide Ion: Generation and Chemical Implications. , 2016, Chemical reviews.
[81] Jie Zhou,et al. Autophagy upregulation promotes macrophages to escape mesoporous silica nanoparticle (MSN)-induced NF-κB-dependent inflammation , 2016, Inflammation Research.
[82] Hongzhuo Liu,et al. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification. , 2016, Materials science & engineering. C, Materials for biological applications.
[83] Linlin Li,et al. Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[84] M. Mahboob,et al. Biomarkers of oxidative stress for in vivo assessment of toxicological effects of iron oxide nanoparticles , 2015, Saudi journal of biological sciences.
[85] Luis Augusto Visani de Luna,et al. Monitoring the Hemolytic Effect of Mesoporous Silica Nanoparticles after Human Blood Protein Corona Formation , 2015 .
[86] Jiandong Wang,et al. Genotoxicity of mesoporous silica nanoparticles in human embryonic kidney 293 cells. , 2015, Drug testing and analysis.
[87] Amalie Thit,et al. Toxic mechanisms of copper oxide nanoparticles in epithelial kidney cells. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.
[88] Ling Zhao,et al. Inflammatory responses and inflammation-associated diseases in organs , 2015, Oncotarget.
[89] Toshiro Hirai,et al. Protein corona changes mediated by surface modification of amorphous silica nanoparticles suppress acute toxicity and activation of intrinsic coagulation cascade in mice , 2015, Nanotechnology.
[90] W. Goessler,et al. Cellular uptake and toxicity effects of silver nanoparticles in mammalian kidney cells , 2015, Journal of applied toxicology : JAT.
[91] Stefan Tenzer,et al. Protein corona of nanoparticles: distinct proteins regulate the cellular uptake. , 2015, Biomacromolecules.
[92] X. Chen,et al. Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-κB signaling pathway , 2014, International journal of nanomedicine.
[93] Y. Yoshioka,et al. Evaluation of silica nanoparticle binding to major human blood proteins , 2014, Nanoscale Research Letters.
[94] V. Rotello,et al. Effect of nano-scale curvature on the intrinsic blood coagulation system. , 2014, Nanoscale.
[95] Chengzhong Yu,et al. Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity. , 2014, Molecular pharmaceutics.
[96] R. Nho,et al. FoxO3a and disease progression. , 2014, World journal of biological chemistry.
[97] M. Moeller,et al. Mechanisms of epithelial repair and regeneration after acute kidney injury. , 2014, Seminars in nephrology.
[98] Tingting Ding,et al. SiO2 nanoparticle-induced impairment of mitochondrial energy metabolism in hepatocytes directly and through a Kupffer cell-mediated pathway in vitro , 2014, International journal of nanomedicine.
[99] F. Alessandrini,et al. Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties , 2014, International journal of nanomedicine.
[100] Jin Sun,et al. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol , 2014, Drug development and industrial pharmacy.
[101] G. Mainelis,et al. Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention , 2014, Cancer biology & medicine.
[102] Xiue Jiang,et al. Impact of shape and pore size of mesoporous silica nanoparticles on serum protein adsorption and RBCs hemolysis. , 2014, ACS applied materials & interfaces.
[103] Alokita Karmakar,et al. Neurotoxicity of nanoscale materials , 2014, Journal of food and drug analysis.
[104] B. Trewyn,et al. Mimicking red blood cell lipid membrane to enhance the hemocompatibility of large-pore mesoporous silica. , 2014, ACS applied materials & interfaces.
[105] Xiao-ling Fang,et al. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[106] Y. Yoshioka,et al. Acute and chronic nephrotoxicity of platinum nanoparticles in mice , 2013, Nanoscale Research Letters.
[107] M. Avci-Adali,et al. Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood. , 2013, Acta biomaterialia.
[108] J. Xu,et al. Nanosized copper oxide induces apoptosis through oxidative stress in podocytes , 2013, Archives of Toxicology.
[109] M. Bayindir,et al. Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption. , 2013, Journal of materials chemistry. B.
[110] Linlin Li,et al. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. , 2013, Biomaterials.
[111] Eric C. Carnes,et al. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. , 2013, Accounts of chemical research.
[112] B. Trewyn,et al. Interaction effects of mesoporous silica nanoparticles with different morphologies on human red blood cells , 2013 .
[113] Y. Liu,et al. Cardiovascular Toxicity of Different Sizes Amorphous Silica Nanoparticles in Rats After Intratracheal Instillation , 2013, Cardiovascular Toxicology.
[114] Mi‐Sun Kim,et al. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice , 2013, International journal of nanomedicine.
[115] J. Xu,et al. Nano copper induced apoptosis in podocytes via increasing oxidative stress. , 2012, Journal of Hazardous Materials.
[116] Xinglu Huang,et al. The shape effect of PEGylated mesoporous silica nanoparticles on cellular uptake pathway in Hela cells , 2012 .
[117] M. Morille,et al. Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. , 2012, Toxicology.
[118] Jürgen Lademann,et al. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. , 2012, ACS nano.
[119] M. Odén,et al. Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization , 2012, Nanoscale Research Letters.
[120] Y. Liu,et al. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery. , 2012, Colloids and surfaces. B, Biointerfaces.
[121] H. Gu,et al. Molecular confinement in fluorescent magnetic mesoporous silica nanoparticles: effect of pore size on multifunctionality. , 2012, Chemphyschem : a European journal of chemical physics and physical chemistry.
[122] D. Basile,et al. Pathophysiology of acute kidney injury. , 2012, Comprehensive Physiology.
[123] Linlin Li,et al. Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.
[124] Zongxi Li,et al. Mesoporous silica nanoparticles in biomedical applications. , 2012, Chemical Society reviews.
[125] Dong Chen,et al. Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. , 2012, Biomaterials.
[126] Michiel Sprik,et al. The Silica-Water Interface: How the Silanols Determine the Surface Acidity and Modulate the Water Properties. , 2012, Journal of chemical theory and computation.
[127] F. Wagener,et al. Heme Oxygenase, Inflammation, and Fibrosis: The Good, the Bad, and the Ugly? , 2012, Front. Pharmacol..
[128] S. Słomkowski,et al. Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro , 2012, Nanotoxicology.
[129] Zhiwei Sun,et al. Cytotoxicity and mitochondrial damage caused by silica nanoparticles. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[130] Stefan Tenzer,et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.
[131] Taeghwan Hyeon,et al. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. , 2011, Accounts of chemical research.
[132] I. Rahman,et al. FOXO3 Deficiency Leads to Increased Susceptibility to Cigarette Smoke-Induced Inflammation, Airspace Enlargement, and Chronic Obstructive Pulmonary Disease , 2011, The Journal of Immunology.
[133] Dong Chen,et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.
[134] Hamidreza Ghandehari,et al. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. , 2011, ACS nano.
[135] R. Tan,et al. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. , 2011, International journal of pharmaceutics.
[136] Tian Xia,et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.
[137] Victor S-Y Lin,et al. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. , 2011, ACS nano.
[138] Y. Yoshioka,et al. Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages , 2011, Nanoscale research letters.
[139] Yaping Li,et al. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.
[140] Patrick Augustijns,et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[141] Donna D. Zhang,et al. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. , 2010, Antioxidants & redox signaling.
[142] C. Mou,et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. , 2010, Angewandte Chemie.
[143] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles: structural design and applications , 2010 .
[144] Christy L Haynes,et al. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. , 2010, Journal of the American Chemical Society.
[145] N. Jacobsen,et al. Role of oxidative damage in toxicity of particulates , 2010, Free radical research.
[146] Feng Gao,et al. Oxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cells. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[147] María Vallet-Regí,et al. Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15 , 2009 .
[148] J. Pounds,et al. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[149] T. Bein,et al. Tuning drug uptake and release rates through different morphologies and pore diameters of confined mesoporous silica , 2009 .
[150] Patrick Brochard,et al. In vitro effects of nanoparticles on renal cells , 2008, Particle and Fibre Toxicology.
[151] C. Hoppel,et al. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. , 2008, American journal of physiology. Cell physiology.
[152] Chung-Yuan Mou,et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. , 2007, Biomaterials.
[153] Patrick Augustijns,et al. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. , 2007, Chemical communications.
[154] G. Stucky,et al. Oxide hemostatic activity. , 2006, Journal of the American Chemical Society.
[155] Shilun Qiu,et al. Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica , 2006 .
[156] Takafumi Yoshida,et al. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production , 2006, Oncogene.
[157] Christopher J. Parsons,et al. Mechanisms of liver fibrosis. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[158] B. Rehermann,et al. The liver as an immunological organ , 2006, Hepatology.
[159] G. Wolf,et al. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. , 2005, Diabetes.
[160] B. Rehermann,et al. The liver as an immunological organ , 2004 .
[161] Bice Fubini,et al. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. , 2003, Free radical biology & medicine.
[162] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[163] R. Gaynor,et al. Role of the NF-kappaB pathway in the pathogenesis of human disease states. , 2001, Current molecular medicine.
[164] K. Itoh,et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.
[165] B. Morrow,et al. Surface vibrational modes of silanol groups on silica , 1992 .
[166] Valerie C. Scanlon,et al. Essentials of Anatomy and Physiology , 1991 .
[167] A. Saboury,et al. Mesoporous silica nanoparticles for therapeutic/diagnostic applications. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[168] A. Farghali,et al. Cardiac and pulmonary toxicity of mesoporous silica nanoparticles is associated with excessive ROS production and redox imbalance in Wistar rats. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[169] Qiang Zhang,et al. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers. , 2018, Acta biomaterialia.
[170] M. Lindén. Biodistribution and Excretion of Intravenously Injected Mesoporous Silica Nanoparticles: Implications for Drug Delivery Efficiency and Safety. , 2018, The Enzymes.
[171] Yubin Li,et al. The Role of Autophagy in Nanoparticles-Induced Toxicity and Its Related Cellular and Molecular Mechanisms. , 2018, Advances in experimental medicine and biology.
[172] Mohanan P V,et al. Cellular interactions of zinc oxide nanoparticles with human embryonic kidney (HEK 293) cells. , 2017, Colloids and surfaces. B, Biointerfaces.
[173] Q. Qian. Inflammation: A Key Contributor to the Genesis and Progression of Chronic Kidney Disease. , 2017, Contributions to nephrology.
[174] S. Sapino,et al. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[175] P. Sil,et al. Nanotoxicity: oxidative stress mediated toxicity of metal and metal oxide nanoparticles. , 2014, Journal of nanoscience and nanotechnology.
[176] H. Schlitt,et al. [The liver as an immunological organ]. , 2011, Zeitschrift fur Gastroenterologie.
[177] Marie Carrière,et al. Toxicological consequences of TiO2, SiC nanoparticles and multi-walled carbon nanotubes exposure in several mammalian cell types: an in vitro study , 2010 .
[178] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. , 2009, Small.